Noetik Competitors and Similar CompaniesClear all

Noetik's competitors and similar companies include Envisagenics, Syndivia and Feroscan.
Noetik
Noetik
Noetik is a biotechnology company that focuses on AI-powered cancer treatment solutions.
Envisagenics
Envisagenics
Envisagenics develops a predictive analytics platform for scientists to translate basic discoveries into therapies and reducing time to market for pharmaceutical companies.
Syndivia
Syndivia
Syndivia is a biotechnology company that develops treatment solutions to cancer patients by leveraging microenvironment and anatomical hallmarks for tumors.
Feroscan
Feroscan
Feroscan is a company specializing in the development of personalized cytotoxics.
Founding Date
Founding Date
2022
Founding Date
2014
Founding Date
2014
Founding Date
2014
Type
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
South San Francisco, US HQ
Locations
New York, US HQ
New York, US
Locations
Illkirch-Graffenstaden, FR HQ
Strasbourg, FR
Locations
Paris, FR HQ
Employees
Employees
379% increase
Employees
548% increase
Employees
6
Employees
12

Funding

Latest funding round
Latest funding round
$ 14m (almost 3 years ago)
Latest funding round
$ 2.4m (over 8 years ago)
Latest funding round
$ 2.3m (over 6 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 14m
Total funding raised
$ 3.1m
Total funding raised
$ 3.9m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Envisagenics
HQ
New York, US
Employees
54↑ 8% increase

Envisagenics develops a predictive analytics platform for scientists to translate basic discoveries into therapies and reducing time to market for pharmaceutical companies.

View company
Syndivia
HQ
Illkirch-Graffenstaden, FR
Employees
6

Syndivia is a biotechnology company that develops treatment solutions to cancer patients by leveraging microenvironment and anatomical hallmarks for tumors.

View company
Feroscan
HQ
Paris, FR
Employees
12

Feroscan is a company specializing in the development of personalized cytotoxics.

View company